Personal data
Name: Csaba Bödör
Date of birth: June 7, 1982
Place of birth: Nitra
Nationality: Hungarian
Qualifications
- DSc, Doctor of Academy of Hungarian Sciences (2021)
- Habilitation (2021), Semmelweis University
- Board-certified clinical biochemist (2021), Semmelweis University, Budapest, Hungary
- MSc degree (2020): Healthcare Manager, Health Services Management Training Centre, Semmelweis University, Budapest, Hungary
- PhD degree (2008): Molecular Oncology program, Doctoral School of Pathology, Semmelweis University, Budapest, Hungary
- MSc degree (2005): Molecular biologist, specialization: immunology, Eötvös Loránd University of Natural Sciences, Budapest, Hungary
Positions
- 2022: Professor in Molecular Oncohematology, Semmelweis University, Department of Pathology and Experimental Cancer Research
- 2015-present: Group leader, MTA-SE Lendulet Molecular Oncohematology Research group
- 2014-present : Semmelweis University, Department of Pathology and Experimental Cancer Research (Senior research fellow)
- 2013-2016: Barts Cancer Institute, Centre for Haemato-Oncology, London (Honorary research fellow)
- 2010-2013: Barts Cancer Institute, Centre for Haemato-Oncology, London (Postdoctoral research fellow)
- 2008-2009: Semmelweis University, Department of Pathology and Experimental Cancer Research (Research associate)
- 2005-2008: Semmelweis Universtiy, Department of Pathology and Experimental Cancer Research (PhD student)
Field of interest
- Molecular genomics and pathogenesis of lymphomas
- Genomics, epigenetics
- Personalised medicine, targeted therapy
Memberships
- Elected board member of the Hungarian Society of Personalized Medicine (2020)
- Representative of the Semmelweis University in the Eurolife international consortium (2019)
- Elected member of the executive board of the Hungarian Society of Hematology and Transfusion (2013) and secretary (2017)
- Member of the molecular diagnostic board of the EWOG-MDS international group (2017)
- Founding member of the Molecular Pathology workgroup of the Hungarian Society of Personalized Medicine (2012)
- European Hematology Association-EHA (2010)
Independent Grant Funding
- Epigenetic model of Follicular Lymphoma, European Hematology Assocation (EHA) post-doctoral partner fellowship, 3 years (2010-2012); 105.000 EUR.
- Aberrant epigenetic regulation in follicular lymphoma, Szent-Györgyi Albert post-doctoral scholarship, 1 year (2013.05-2014-05); 20.000 EUR.
- Investigation of the genetic background of familial myelodysplastic syndromes (MDS) and acute myeloid leukaemias (AML), OTKA-PD grant, 2 years (2013.09-2015.09); 25.000 EUR
- Personalised medicine in B-cell lymphomas (MTA Momentum grant of the Hungarian Academy of Sciences) (2015-2020); 300.000 EUR.
- Liquid biopsy-based identification and monitoring of novel therapeutic targets in B-cell lymphomas. NKFIH-KH17 grant (2018-2019); 65.000 EUR
- ERA-PERMED Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia (2019-2022). 1.000.000 EUR.
- Liquid biopsy based genomic profiling and minimal residual disease detection in mature B-cell lymphomas. HCEMM Translational Research Group program (2021-2026).
Additional training
- Exome sequencing and data analysis course: Imperial College London (January 2012)
-
Joint EBI-Wellcome Trust Summer school in bioinformatics, Cambridge, UK (2011)